What is MTAC's gross margin?

MedTech (MTAC) has a gross margin of 87% and a net margin of -67%.

What is MTAC's P/E ratio?

Track MedTech (MTAC) P/E ratio, ROE, and valuation metrics over time.

Where can I see MTAC's full financials?

See MedTech (MTAC) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

MedTech (MTAC) Financials — Revenue, Earnings, Cash Flow

Also trades as: MTACW (NASDAQ) · $vol 0M · MTACU (NASDAQ) · $vol 0M

$11.34

Last traded 2023-08-10 — delisted

NASDAQ · Financial Services · Shell Companies · $83.9M mcap · 1M float · 0.217% daily turnover

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$45M

Revenue

-21.1% YoY

$-56M

Net Income

-159.1% YoY

$-23M

Free Cash Flow

+62.5% YoY

86.8%

Gross Margin

-86.0%

Op. Margin

-67.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE865.5%

ROA-107.4%

ROIC453.7%

Valuation

P/E-8.7

P/B95.1

EV/EBITDA-58.8

Leverage

Debt/Equity5.26

Current Ratio5.35

Interest Cov.0.0x

Quality Scores

Piotroski F3/9

Altman Z0.76

Beneish M-5.12